top of page

immunology CRO

CASE STUDIES >  AI-DRIVEN INSIGHT & CONSULTANCY

Funnel Growth for an AI-Driven Pharma Consultancy Focused on Vaccine and Therapy Adoption

A European AI insight and consultancy firm had a technically compelling product but needed a targeted go-to-market strategy to reach high-level decision-makers in the vaccine and pharmaceutical space.

Key Results in 12 weeks

  • 37% engagement rate — more than double the industry benchmark of 10–15%
     

  • 22 total replies generated, resulting in 17 active conversations
     

  • All results delivered within a 12-week campaign targeting 14 vaccine companies and 448 stakeholders

Untitled design (3).png

The Challenge

The client is a Europe-based AI insight and consultancy firm with over 20 years in business and a team of 75 FTEs, specialising in Digital Transformation and AI for the pharmaceutical and public health sectors.

Their product — an AI-powered solution for improving therapy and vaccination uptake — combines real-world data, machine learning, and expert consulting to help pharma teams understand what drives or hinders adoption.
 

While technically strong, they needed a targeted go-to-market strategy to reach high-level decision-makers and vaccine research authors, ensuring messaging resonated with their ideal customers.

 

Key obstacles included:
 

  • Identifying and reaching high-intent leads across a highly specialised niche
     

  • Accessing senior decision-makers at global vaccine companies and research institutions
     

  • Crafting messaging that spoke directly to the pain points of pharma and public health leaders

The Solution

Outbound Pharma ran a 12-week, multi-segment campaign targeting 14 vaccine companies and 448 selected stakeholders across commercial, scientific, and leadership functions. The strategy was built around four core pillars:

​

  • Targeted Outreach — A highly segmented audience was identified and engaged, spanning 14 global vaccine companies (195 contacts), researchers and authors (89 contacts), and commercial leadership (153 contacts). Each segment received tailored messaging aligned to their specific role and priorities.

  • Multi-Channel Engagement — The campaign leveraged a combination of personalised email outreach, direct personal networking, and LinkedIn engagement to maximise visibility and response rates across different communication preferences.

  • Thought Leadership Activation — A dedicated webinar on the role of data intelligence in driving vaccine uptake in pharma and public health was promoted as part of the campaign, positioning the client as an authoritative voice in the space and generating additional inbound interest.

  • Ongoing Optimisation — Throughout the campaign, Outbound Pharma continuously monitored performance metrics, corrected tracking issues, and refined segmentation in real time to maximise results and lay the groundwork for a strong Phase II.

The Results

In the first 12 weeks, the campaign delivered high-quality engagement metrics that significantly outperformed industry standards.

​

  • Achieved a 37% engagement rate, more than doubling the industry benchmark of 10-15%.

  • Generated 22 total replies, resulting in 17 active conversations.

  • Identified specific areas for improvement, and a recommendations.

Prêt à obtenir de meilleurs prospects ?

bottom of page